☆ 4.7 Article

Erdafitinib in BCG-treated high-risk non-muscle-invasive bladder cancer

ANNALS OF ONCOLOGY (2023)

Journal

ANNALS OF ONCOLOGY

Volume -, Issue -, Pages -

Publisher

Elsevier BV

DOI: 10.1016/j.annonc.2023.09.3116

Keywords

-

Categories

Oncology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.